HNL Lab Medicine Celebrates Preferred Partnership With Roche Diagnostics

The partnership aims to enhance laboratory performance and improve patient care through innovative technologies and solutions.

Apr. 7, 2026 at 2:09pm

Got story updates? Submit your updates here. ›

A high-end, photorealistic studio still-life photograph featuring a collection of premium medical diagnostic equipment and tools, including a microscope, test tubes, and other lab instruments, arranged elegantly on a clean, monochromatic seamless background, conceptually representing the precision and innovation of the HNL Lab Medicine and Roche Diagnostics partnership.The strategic partnership between HNL Lab Medicine and Roche Diagnostics aims to elevate laboratory performance and enhance patient care through cutting-edge diagnostic technologies and solutions.Allentown Today

HNL Lab Medicine, a leading multi-regional medical laboratory, has announced a preferred partnership with Roche Diagnostics. This collaboration will focus on advancing patient care through the adoption of forward-thinking technologies and solutions that improve speed, accuracy, and the overall patient experience. By working closely with Roche, a global leader in diagnostics, HNL Lab Medicine aims to deliver timely, high-quality diagnostic insights to healthcare providers.

Why it matters

The partnership between HNL Lab Medicine and Roche Diagnostics represents a strategic move to address the evolving challenges faced by the lab industry. By aligning with a trusted partner that shares a focus on innovation and operational excellence, HNL Lab Medicine can enhance its capabilities, streamline operations, and provide better support to healthcare professionals in delivering improved patient outcomes.

The details

Through this preferred partnership, HNL Lab Medicine will have access to Roche's advanced diagnostic solutions, which are designed to help laboratories maximize staff efficiency, reduce turnaround times for critical tests, standardize operations, and minimize waste while supporting sustainability goals. HNL Lab Medicine processes approximately 5.6 million specimens annually, delivering more than 63 million lab results across its network of over 50 patient service centers and 31 acute care laboratories. The partnership aims to further improve the speed and accuracy of HNL Lab Medicine's services, ensuring healthcare providers have the insights they need to make informed clinical decisions.

  • HNL Lab Medicine has been operating for more than 25 years.
  • The preferred partnership with Roche Diagnostics was announced on April 7, 2026.

The players

HNL Lab Medicine

A leading multi-regional, full-service medical laboratory providing testing and related services to healthcare providers throughout Pennsylvania.

Roche Diagnostics

A global leader in diagnostics and a pioneer in personalized healthcare, developing and producing medical tests and digital solutions that provide insights to healthcare professionals.

Warren W. Erdmann

Chief Operating Officer of HNL Lab Medicine.

Got photos? Submit your photos here. ›

What they’re saying

“The essence behind our preferred partnership recognition is to foster long-term alignment with partners we trust, enabling us to address these challenges together. By working closely with our valued partners, we can find mutually beneficial solutions, offer flexibility when needed, and collaborate to achieve win-win successes.”

— Warren W. Erdmann, Chief Operating Officer, HNL Lab Medicine

“HNL Lab Medicine is a growth lab, and with many new and exciting opportunities emerging, we believe that our success is deeply intertwined with the contributions and support of our partners. We are committed to enabling and sharing in that success, reinforcing that we cannot move forward without those who bring value to our collaborative efforts.”

— Warren W. Erdmann, Chief Operating Officer, HNL Lab Medicine

What’s next

HNL Lab Medicine and Roche Diagnostics will continue to work closely together to implement the new partnership and explore additional ways to enhance laboratory performance and improve patient care through innovative technologies and solutions.

The takeaway

The preferred partnership between HNL Lab Medicine and Roche Diagnostics represents a strategic move to address the evolving challenges faced by the lab industry. By aligning with a trusted partner that shares a focus on innovation and operational excellence, HNL Lab Medicine can enhance its capabilities, streamline operations, and provide better support to healthcare professionals in delivering improved patient outcomes.